Clinical Study
Selective Laser Trabeculoplasty for Glaucoma Secondary to Emulsified Silicone Oil after Pars Plana Vitrectomy: A Pilot Study
Table 1
Demographic and clinical characteristics and selective laser trabeculoplasty parameters.
| | Variables | Patients () |
| | Age (years), mean ± SD (range) | 38.2 ± 16.6 (19–74) | | Gender, male/female | 7/4 | | Number of medications before SLT, mean ± SD (range) | 2.9 ± 0.8 (2–4) | | Pre-SLT Snellen BCVA (%) | | | >20/200 | 1 (9%) | | <20/200-CF | 6 (54.6%) | | ≤HM | 4 (36.4%) | | PreSLT IOP (mmHg), mean ± SD (range) | 25 ± 2.7 (21–28) | | SLT parameters | | | Number of laser spots, mean ± SD (range) | 113 ± 45 (50–160) | | Total energy (mJ), mean ± SD (range) | 0.82 ± 0.16 (0.7–1.1) | | Degree of angle treated, mean ± SD (range) | 184 ± 43 (120–270) |
|
|
SD: standard deviation; SLT: selective laser trabeculoplasty; BCVA: best corrected visual acuity; CF: counting fingers; HM: hand motion; IOP: intraocular pressure.
|
